Association of road-traffic accidents with benzodiazepine use

Lancet

Volumn 352, Issue 9137, 1998, Pages 1331-1336

  Barbone, F ^a   McMahon, A D ^a   Davey, P G ^a   Morris, A D ^a   Reid, I C ^b   McDevitt, D G ^a   MacDonald, T M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMOXAPINE; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORDIAZEPOXIDE; CLOMIPRAMINE; CLORAZEPATE; DESIPRAMINE; DIAZEPAM; DOSULEPIN; DOXEPIN; FLUNITRAZEPAM; IMIPRAMINE; LOFEPRAMINE; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MAPROTILINE; MIANSERIN; NEUROLEPTIC AGENT; NITRAZEPAM; NORTRIPTYLINE; OXAZEPAM; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOPICLONE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRIVING ABILITY; DRUG HALF LIFE; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK; TRAFFIC ACCIDENT; UNITED KINGDOM;

EID: 0032564174     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)04087-2     Document Type: Article

References (31)

1. 1 Hindmarch I. The effects of psychoactive drugs on car handling and related psychomotor ability: a review. In: O'Hanlon JF, de Grier JJ, eds. Drugs and driving. Philadelphia: Taylor & Francis, 1986: 71-82.
2. 2 Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873-83.
3. 3 Currie D, Hashemi K, Fothergill J, Finlay A, Harris A, Hindmarch I. The use of anti-depressants and benzodiazepines in the perpetrators and victims of accidents. Occup Med 1995; 45: 323-25.
4. 4 Hemmelgarn B, Suissa S, Huang A, Boivin J-F, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278: 27-31.
5. 5 Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. Psychoactive medications and injurious motor vehicle accidents involving older drivers. Epidemiology 1994; 5: 591-98.
6. 6 Skegg DCG, Richards SM, Doll R. Minor tranquilisers and road accidents. BMJ 1979; i: 917-19.
7. 7 Honakanen R, Ertama L, Linnoila M, et al. Role of drugs in traffic accidents. BMJ 1980; 281: 1309-12.
8. 8 Lundberg GD. Let's stop driving after drinking and using other psychoactive drugs. JAMA 1986; 255: 529-30.
9. 9 Alvarez FJ, Del Rio MC. Drugs and driving. Lancet 1994; 344: 282.
10. 10 Ramaekers JG, Muntjewerff ND, O'Hanlon JF. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 1995; 39: 397-404.
11. 11 De Gier JJ. Driving licences and known use of licit or illicit drugs (IHP 93-39). Maastricht: University of Limburg, Institute for Human Psychopharmacology, 1993.
12. 12 Edwards JG. Depression, antidepressants, and accidents: pharmacological concerns need epidemiological elucidation. BMJ 1995; 311: 887-88.
13. 13 Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-53.
14. 14 Evans JMM, McDevitt DG, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance. Pharmaceut Med 1995; 9: 177-84.
15. 15 MacDonald TM, McDevitt DG. The Tayside Medicines Monitoring Unit. In: Strom BL, ed. Pharmacoepidemiology, 2nd edn. Chichester: John Wiley, 1994: 245-55.
16. 16 Beardon PHG, Brown SV, McGilchrist MM, McKendick AD, McDevitt DG, MacDonald TM. Primary non compliance with prescribed medication in primary care. BMJ 1993; 307: 846-48.
17. 17 Rothman KJ, Greenland S. Matching. In: Rothman KJ, Greenland S, eds. Modern epidemiology, 2nd edn. Philadelphia: Lippincott-Raven, 1998: 147-61.
18. 18 MacDonald TM, McMahon AD, Reid IC, Fenton GW, McDevitt DG. Antidepressant drug use in primary care: a record-linkage study in Tayside, Scotland. BMJ 1996; 313: 860-86.
19. 19 Suissa S. The case-time-control design. Epidemiology 1995; 6: 248-53.
20. 20 Hobbs WR, Rall TW, Verdoorn TA. Hypnotics and sedatives; ethanol. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A. Goodman & Gilman's The pharmacological basis of therapeutics, 9th edn. New York: McGraw-Hill, 1996: 361-96.
21. 21 British Medical association and Royal Pharmaceutical Society of Great Britain. British National Formulary, number 30. London: BMA and Pharmaceutical Press, September 1995.
22. 22 Borkenstein RF, Crowther RF, Shumate RP, Zylman R. The role of the drinking driver in traffic accidents (The Grand Rapids Study). Blutalkohol 1974; 11(suppl 1): 7-13.
23. 23 Redelmeier DA, Tibshirani RJ. Association between cellular-telephone calls and motor vehicle collisions. N Engl J Med 1997; 336: 453-58.
24. 24 Donoghue JM, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996; 168: 164-68.
25. 25 Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse and consequences. Pharmacol Rev 1992; 44: 151-347.
26. 26 American Psychiatric Task Force on benzodiazepine dependence, toxicity and abuse. Washington DC: American Psychiatric Press, 1990.
27. 27 Volkerts ER, O'Hanlon JF. Residual effects of real car driving performance: zopiclone versus flunitrazepam and nitrazepam. J Drug Ther Res 1988; 13: 111-14.
28. 28 Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 1997; 7: 568-74.
29. 29 van der Waals F, Mohrs J, Foets M. Sex differences amongs recipients of benzodiazepines in Dutch general practices. BMJ 1993; 307: 363-66.
30. 30 Department of the Environment, Transport and the Regions. Road accidents Great Britain 1996: the causality report. London: Stationery Office, 1997.
31. 31 British Medical Association Board of Science and Education. Driving impairment through alcohol and other drugs. London: BMA, 1996.